Related Experiment Video
Updated: Jul 18, 2026
14:54
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
Published on: September 11, 2023
Vitreous fluid biomarkers.
Hideharu Funatsu1, Tetsuji Yamashita, Hidetoshi Yamashita
1Department of Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Advances in Clinical Chemistry
|November 30, 2006
Summary
Vitreous fluid analysis aids in diagnosing ocular diseases when clinical presentation is unclear. Biomarker quantification and understanding vitreous fluid
Area of Science:
- Ophthalmology
- Molecular Biology
- Biochemistry
Background:
- Cell-secreted protein interactions are implicated in ocular disease pathogenesis.
- Clinical diagnosis is often sufficient, but atypical presentations necessitate further testing.
- Advances in molecular biology and surgical tools enhance diagnostic capabilities.
Purpose of the Study:
- To review vitreous fluid sampling techniques.
- To discuss biomarker quantitation in vitreous fluid.
- To explore the role of vitreous fluid factors in ocular disease development.
Main Methods:
- Review of current literature on vitreous fluid sampling.
- Analysis of molecular biology techniques for biomarker assessment.
- Discussion of pathophysiological processes in ocular diseases.
Main Results:
- Vitreous fluid sampling provides crucial diagnostic information for atypical ocular conditions.
- Biomarker analysis offers insights into disease mechanisms.
- Understanding vitreous fluid composition aids in developing new therapies.
Conclusions:
- Vitreous fluid analysis is a valuable tool for diagnosing and managing ocular diseases.
- Molecular insights into vitreous fluid factors are key to advancing ophthalmology.
- Technological progress continues to improve diagnostic and therapeutic options for eye conditions.
